Non-cultural methods for the diagnosis of invasive fungal disease

References

• Bitar D, Lortholary O, Le Strat Y, et al. Population-based analysis of invasive fungal infections, France, 2001–2010. Emerg Infect Dis 2014;20:1163-9
   Google Scholar
• Mikulska M, Del Bono V, Ratto S, Viscoli C. Occurrence, presentation and treatment of candidemia. Expert Rev Clin Immunol 2012;8:755-65
   PubMed Web of Science ®Google Scholar
• Marchetti O, Lamoth F, Mikulska M, et al. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant 2012;47:846-54
   PubMed Web of Science ®Google Scholar
• Maertens J, Theunissen K, Verhoef G, et al. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study. Clin Infect Dis 2005;41:1242-50
   PubMed Web of Science ®Google Scholar
• Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002;34:7-14
   PubMed Web of Science ®Google Scholar
• Maertens JA, Klont R, Masson C, et al. Optimization of the cutoff value for the Aspergillus double-sandwich enzyme immunoassay. Clin Infect Dis 2007;44:1329-36
   PubMed Web of Science ®Google Scholar
• Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta-analysis. Clin Infect Dis 2006;42:1417-27
   PubMed Web of Science ®Google Scholar
• Leeflang MM, Debets-Ossenkopp YJ, Visser CE, et al. Galactomannan detection for invasive aspergillosis in immunocompromized patients. Cochrane Database Syst Rev 2008;CD007394
   Google Scholar
• Rimek D, Zimmermann T, Hartmann M, et al. Disseminated Penicillium marneffei infection in an HIV-positive female from Thailand in Germany. Mycoses 1999;42(Suppl 2):25-8
   Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diagn Microbiol Infect Dis 2012;72:367-9
   PubMed Web of Science ®Google Scholar
• Nucci M, Carlesse F, Cappellano P, et al. Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing. PLoS One 2014;9:e87784
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Esposto MC, Prigitano A, et al. Cross-reactivity of Fusarium spp. in the Aspergillus galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012;50:1051-3
   PubMed Web of Science ®Google Scholar
• Kappe R, Schulze-Berge A. New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993;31:2489-90
   PubMed Web of Science ®Google Scholar
• Ozkaya-Parlakay A, Cengiz AB, Karadag-Oncel E, et al. Geotrichum capitatum septicemia in a hematological malignancy patient with positive galactomannan antigen: case report and review of the literature. Turkish J Pediatr 2012;54:674-8
   PubMed Web of Science ®Google Scholar
• Cummings JR, Jamison GR, Boudreaux JW, et al. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diagn Microbiol Infect Dis 2007;59:113-15
   PubMed Web of Science ®Google Scholar
• Narreddy S, Chandrasekar PH. False-positive Aspergillus galactomannan (GM) assay in histoplasmosis. J Infect 2008;56:80-1
   PubMedGoogle Scholar
• Vergidis P, Walker RC, Kaul DR, et al. False-positive Aspergillus galactomannan assay in solid organ transplant recipients with histoplasmosis. Transpl Infect Dis 2012;14:213-17
   PubMed Web of Science ®Google Scholar
• Van Der Veer J, Lewis RJ, Emtiazjoo AM, et al. Cross-reactivity in the Platelia Aspergillus enzyme immunoassay caused by blastomycosis. Med Mycol 2012;50:396-8
   PubMed Web of Science ®Google Scholar
• Petti MC, Prignano G, Mengarelli A, et al. Cross-recognition of aspergillus galactomannan caused by Listeria monocytogenes infection. Diagn Microbiol Infect Dis 2013;76:250-1
   PubMedGoogle Scholar
• Sulahian A, Touratier S, Ribaud P. False positive test for aspergillus antigenemia related to concomitant administration of piperacillin and tazobactam. N Engl J Med 2003;349:2366-7
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Cappellano P, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin–tazobactam. Clin Infect Dis 2004;38:913-16
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. Piperacillin/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay. J Antimicrob Chemother 2012;67:1746-8
   PubMed Web of Science ®Google Scholar
• Vergidis P, Razonable RR, Wheat LJ, et al. Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. J Clin Microbiol 2014;52:2199-201
   PubMed Web of Science ®Google Scholar
• Xavier MO, Pasqualotto AC, Aquino VR, et al. Galactomannan detection from piperacillin-tazobactam brands available in the Brazilian market. Brazilian J Infect Dis 2009;13:353-5
   PubMedGoogle Scholar
• Gerlinger MP, Rousselot P, Rigaudeau S, et al. False positive galactomannan Platelia due to piperacillin–tazobactam. Med Mal Infect 2012;42:10-14
   PubMedGoogle Scholar
• Hachem RY, Kontoyiannis DP, Chemaly RF, et al. Utility of galactomannan enzyme immunoassay and (1,3) beta-D-glucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J Clin Microbiol 2009;47:129-33
   PubMed Web of Science ®Google Scholar
• Xavier MO, Araujo JS, Aquino VR, et al. Variability in Galactomannan detection by Platelia Aspergillus EIA according to the Aspergillus species. Rev Inst Med Trop S Paulo 2013;55
   Google Scholar
• Swanink CM, Meis JF, Rijs AJ, et al. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997;35:257-60
   PubMed Web of Science ®Google Scholar
• Martin-Rabadan P, Gijon P, Alonso Fernandez R, et al. False-positive Aspergillus antigenemia due to blood product conditioning fluids. Clin Infect Dis 2012;55:e22-7
   Google Scholar
• Asano-Mori Y, Kanda Y, Oshima K, et al. False-positive Aspergillus galactomannan antigenaemia after haematopoietic stem cell transplantation. J Antimicrob Chemother 2008;61:411-16
   PubMed Web of Science ®Google Scholar
• Siemann M, Koch-Dorfler M, Gaude M. False-positive results in premature infants with the Platelia Aspergillus sandwich enzyme-linked immunosorbent assay. Mycoses 1998;41:373-7
   PubMed Web of Science ®Google Scholar
• Marr KA, Laverdiere M, Gugel A, Leisenring W. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin Infect Dis 2005;40:1762-9
   PubMed Web of Science ®Google Scholar
• McCulloch E, Ramage G, Rajendran R, et al. Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis. J Clin Pathol 2012;65:83-6
   PubMedGoogle Scholar
• Hoenigl M, Seeber K, Koidl C, et al. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Mycoses 2013;56:471-6
   PubMed Web of Science ®Google Scholar
• Wingard JR, Carter SL, Walsh TJ, et al. Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 2010;116:5111-18
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Donnelly JP, Verweij PE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis 2004;4:349-57
   PubMed Web of Science ®Google Scholar
• Bergeron A, Belle A, Sulahian A, et al. Contribution of galactomannan antigen detection in BAL to the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies. Chest 2010;137:410-15
   PubMed Web of Science ®Google Scholar
• Becker MJ, Lugtenburg EJ, Cornelissen JJ, et al. Galactomannan detection in computerized tomography-based broncho-alveolar lavage fluid and serum in haematological patients at risk for invasive pulmonary aspergillosis. Br J Haematol 2003;121:448-57
   PubMed Web of Science ®Google Scholar
• Park SY, Lee SO, Choi SH, et al. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Infect 2010;61:492-8
   PubMed Web of Science ®Google Scholar
• Maertens J, Maertens V, Theunissen K, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis 2009;49:1688-93
   PubMed Web of Science ®Google Scholar
• Luong ML, Clancy CJ, Vadnerkar A, et al. Comparison of an Aspergillus real-time polymerase chain reaction assay with galactomannan testing of bronchoalvelolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in lung transplant recipients. Clin Infect Dis 2011;52:1218-26
   PubMed Web of Science ®Google Scholar
• Meersseman W, Lagrou K, Maertens J, et al. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients. Am J Respir Crit Care Med 2008;177:27-34
   PubMed Web of Science ®Google Scholar
• Acosta J, Catalan M, del Palacio-Perez-Medel A, et al. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1–> 3)-beta-d-glucan chromogenic assay in serum samples. Clin Microbiol Infect 2011;17:1053-60
   PubMed Web of Science ®Google Scholar
• Guo YL, Chen YQ, Wang K, et al. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 2010;138:817-24
   PubMed Web of Science ®Google Scholar
• Heng SC, Morrissey O, Chen SC, et al. Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: A systematic review and meta-analysis. Crit Rev Microbiol 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Zou M, Tang L, Zhao S, et al. Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis. PLoS One 2012;7:e43347
   PubMed Web of Science ®Google Scholar
• Avni T, Levy I, Sprecher H, et al. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review. J Clin Microbiol 2012;50:3652-8
   PubMed Web of Science ®Google Scholar
• Luong ML, Filion C, Labbe AC, et al. Clinical utility and prognostic value of bronchoalveolar lavage galactomannan in patients with hematologic malignancies. Diagn Microbiol Infect Dis 2010;68:132-9
   PubMed Web of Science ®Google Scholar
• D’Haese J, Theunissen K, Vermeulen E, et al. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J Clin Microbiol 2012;50:1258-63
   PubMed Web of Science ®Google Scholar
• Viscoli C, Machetti M, Gazzola P, et al. Aspergillus galactomannan antigen in the cerebrospinal fluid of bone marrow transplant recipients with probable cerebral aspergillosis. J Clin Microbiol 2002;40:1496-9
   PubMed Web of Science ®Google Scholar
• Verweij PE, Brinkman K, Kremer HP, et al. Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management. J Clin Microbiol 1999;37:1186-9
   PubMed Web of Science ®Google Scholar
• Antinori S, Corbellino M, Meroni L, et al. Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. J Infect 2013;66:218-38
   PubMed Web of Science ®Google Scholar
• Soeffker G, Wichmann D, Loderstaedt U, et al. Aspergillus galactomannan antigen for diagnosis and treatment monitoring in cerebral aspergillosis. Progress Trans (Aliso Viejo, Calif.) 2013;23:71-4
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21
   PubMed Web of Science ®Google Scholar
• Miceli MH, Grazziutti ML, Woods G, et al. Strong correlation between serum aspergillus galactomannan index and outcome of aspergillosis in patients with hematological cancer: clinical and research implications. Clin Infect Dis 2008;46:1412-22
   PubMed Web of Science ®Google Scholar
• Bergeron A, Porcher R, Menotti J, et al. Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients. J Clin Microbiol 2012;50:823-30
   PubMed Web of Science ®Google Scholar
• Chai LY, Kullberg BJ, Johnson EM, et al. Early serum galactomannan trend as a predictor of outcome of invasive aspergillosis. J Clin Microbiol 2012;50:2330-6
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Baden LR, Marty FM. Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 2010;48:1255-60
   PubMed Web of Science ®Google Scholar
• Park SH, Choi SM, Lee DG, et al. Serum galactomannan strongly correlates with outcome of invasive aspergillosis in acute leukaemia patients. Mycoses 2011;54:523-30
   PubMedGoogle Scholar
• Fisher CE, Stevens AM, Leisenring W, et al. The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis. Clin Infect Dis 2013;57:1001-4
   PubMed Web of Science ®Google Scholar
• Mikulska M, Raiola AM, Signori A, et al. Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis. Clin Infect Dis 2013;57:1786-7
   PubMedGoogle Scholar
• Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol 2008;15:1095-105
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Thornton CR, Najvar LK, et al. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccine Immunol 2009;16:1844-6
   PubMed Web of Science ®Google Scholar
• Wiederhold NP, Najvar LK, Bocanegra R, et al. Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis. J Clin Microbiol 2013;51:459-65
   PubMed Web of Science ®Google Scholar
• Held J, Schmidt T, Thornton CR, et al. Comparison of a novel Aspergillus lateral-flow device and the Platelia(R) galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection 2013;41:1163-9
   PubMed Web of Science ®Google Scholar
• White PL, Parr C, Thornton C, Barnes RA. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol 2013;51:1510-16
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Koidl C, Duettmann W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect 2012;65:588-91
   PubMed Web of Science ®Google Scholar
• Willinger B, Lackner M, Lass-Florl C, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a Semiprospective Multicenter Study. Transplantation 2014;98(8):898-902
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 2014;52:2039-45
   PubMed Web of Science ®Google Scholar
• Obayashi T, Yoshida M, Mori T, et al. Plasma (1–>3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995;345:17-20
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Paetznick VL, Rodriguez JR, et al. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006;44:267-72
   PubMed Web of Science ®Google Scholar
• Lamoth F, Cruciani M, Mengoli C, et al. Beta-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012;54:633-43
   PubMed Web of Science ®Google Scholar
• Senn L, Robinson JO, Schmidt S, et al. 1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-85
   PubMed Web of Science ®Google Scholar
• Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1–>3)-beta-D-glucan assay for the diagnosis of invasive fungal infections–a study based on autopsy cases from 6 years. Clin Infect Dis 2008;46:1864-70
   PubMed Web of Science ®Google Scholar
• Kondori N, Edebo L, Mattsby-Baltzer I. Circulating beta (1-3) glucan and immunoglobulin G subclass antibodies to Candida albicans cell wall antigens in patients with systemic candidiasis. Clin Diagn Lab Immunol 2004;11:344-50
   PubMedGoogle Scholar
• Poissy J, Sendid B, Damiens S, et al. Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation. Crit Care 2014;18:R135
   Web of Science ®Google Scholar
• Jaijakul S, Vazquez JA, Swanson RN, Ostrosky-Zeichner L. (1,3)-beta-D-glucan as a prognostic marker of treatment response in invasive candidiasis. Clin Infect Dis 2012;55:521-6
   PubMed Web of Science ®Google Scholar
• Odabasi Z, Mattiuzzi G, Estey E, et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205
   PubMed Web of Science ®Google Scholar
• Furfaro E, Mikulska M, Del Bono V, et al. Bloodstream infections are an improbable cause of positive serum (1,3)-beta-D-glucan in hematology patients. Clin Vaccine Immunol 2014;21:1357-9
   PubMed Web of Science ®Google Scholar
• Racil Z, Kocmanova I, Toskova M, et al. Reactivity of the 1,3-beta-D-glucan assay during bacteraemia: limited evidence from a prospective study. Mycoses 2013;56:101-4
   PubMed Web of Science ®Google Scholar
• Albert O, Toubas D, Strady C, et al. Reactivity of (1–>3)-beta-d-glucan assay in bacterial bloodstream infections. Eur J Clin Microbiol Infect Dis 2011;30:1453-60
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos DE, Vouloumanou EK, Ntziora F, et al. beta-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin Infect Dis 2011;52:750-70
   PubMed Web of Science ®Google Scholar
• Onishi A, Sugiyama D, Kogata Y, et al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis. J Clin Microbiol 2012;50:7-15
   PubMed Web of Science ®Google Scholar
• Lu Y, Chen YQ, Guo YL, et al. Diagnosis of invasive fungal disease using serum (1–>3)-beta-D-glucan: a bivariate meta-analysis. Intern Med 2011;50:2783-91
   PubMed Web of Science ®Google Scholar
• Karageorgopoulos DE, Qu JM, Korbila IP, et al. Accuracy of beta-D-glucan for the diagnosis of Pneumocystis jirovecii pneumonia: a meta-analysis. Clin Microbiol Infect 2013;19:39-49
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Viscoli C. Biomarkers for diagnosis and follow-up of invasive candidiasis: a brief review of the ECIL recommendations. Curr Fungal Infect Reports 2012;6:192-7
   Google Scholar
• Hanson KE, Pfeiffer CD, Lease ED, et al. beta-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS One 2012;7:e42282
   PubMed Web of Science ®Google Scholar
• Persat F, Ranque S, Derouin F, et al. Contribution of the (1–>3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008;46:1009-13
   PubMed Web of Science ®Google Scholar
• Ellis M, Al-Ramadi B, Finkelman M, et al. Assessment of the clinical utility of serial beta-D-glucan concentrations in patients with persistent neutropenic fever. J Med Microbiol 2008;57:287-95
   PubMed Web of Science ®Google Scholar
• Tissot F, Lamoth F, Hauser PM, et al. beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 2013;188:1100-9
   PubMed Web of Science ®Google Scholar
• Koo S, Baden LR, Marty FM. Post-diagnostic kinetics of the (1 –> 3)-beta-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumonia. Clin Microbiol Infect 2012;18:E122-7
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. Clin Vaccine Immunol 2011;18:518-19
   PubMedGoogle Scholar
• Ostrosky-Zeichner L, Alexander BD, Kett DH, et al. Multicenter clinical evaluation of the (1–>3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005;41:654-9
   PubMed Web of Science ®Google Scholar
• Del Bono V, Delfino E, Furfaro E, et al. Clinical performance of the (1,3)-beta-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. Clin Vaccine Immunol 2011;18:2113-17
   PubMed Web of Science ®Google Scholar
• Koo S, Bryar JM, Page JH, et al. Diagnostic performance of the (1–>3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis 2009;49:1650-9
   PubMed Web of Science ®Google Scholar
• Kawazu M, Kanda Y, Nannya Y, et al. Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked immunosorbent assay for galactomannan, and a (1–>3)-beta-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders. J Clin Microbiol 2004;42:2733-41
   PubMed Web of Science ®Google Scholar
• Pazos C, Ponton J, Del Palacio A. Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 2005;43:299-305
   PubMed Web of Science ®Google Scholar
• Rose SR, Vallabhajosyula S, Velez MG, et al. The utility of bronchoalveolar lavage beta-D-glucan testing for the diagnosis of invasive fungal infections. J Infect 2014;69:278-83
   PubMed Web of Science ®Google Scholar
• Litvintseva AP, Lindsley MD, Gade L, et al. Utility of (1-3)-beta-D-glucan testing for diagnostics and monitoring response to treatment during the multistate outbreak of fungal meningitis and other infections. Clin Infect Dis 2014;58:622-30
   PubMed Web of Science ®Google Scholar
• Lyons JL, Roos KL, Marr KA, et al. Cerebrospinal fluid (1,3)-beta-D-glucan detection as an aid for diagnosis of iatrogenic fungal meningitis. J Clin Microbiol 2013;51:1285-7
   PubMed Web of Science ®Google Scholar
• Mikulska M, Furfaro E, Del Bono V, et al. (1-3)-beta-D-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. Clin Infect Dis 2013;56:1511-12
   PubMed Web of Science ®Google Scholar
• Petraitiene R, Petraitis V, Hope WW, et al. Cerebrospinal fluid and plasma (1–>3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis. Antimicrob Agents Chemother 2008;52:4121-9
   PubMed Web of Science ®Google Scholar
• Kourkoumpetis TK, Fuchs BB, Coleman JJ, et al. Polymerase chain reaction-based assays for the diagnosis of invasive fungal infections. Clin Infect Dis 2012;54:1322-31
   PubMed Web of Science ®Google Scholar
• Morrissey CO, Chen SC, Sorrell TC, et al. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect Dis 2013;13:519-28
   PubMed Web of Science ®Google Scholar
• White PL, Perry MD, Barnes RA. An update on the molecular diagnosis of invasive fungal disease. FEMS Microbiol Lett 2009;296:1-10
   PubMed Web of Science ®Google Scholar
• White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010;48:1231-40
   PubMed Web of Science ®Google Scholar
• White PL, Mengoli C, Bretagne S, et al. Evaluation of Aspergillus PCR protocols for testing serum specimens. J Clin Microbiol 2011;49:3842-8
   PubMed Web of Science ®Google Scholar
• Barnes RA, White PL, Bygrave C, et al. Clinical impact of enhanced diagnosis of invasive fungal disease in high-risk haematology and stem cell transplant patients. J Clin Pathol 2009;62:64-9
   PubMed Web of Science ®Google Scholar
• Mennink-Kersten MA, Ruegebrink D, Wasei N, et al. In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-D-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 2006;44:1711-18
   PubMed Web of Science ®Google Scholar
• Mengoli C, Cruciani M, Barnes RA, et al. Use of PCR for diagnosis of invasive aspergillosis: systematic review and meta-analysis. Lancet Infect Dis 2009;9:89-96
   PubMed Web of Science ®Google Scholar
• White PL, Perry MD, Moody A, et al. Evaluation of analytical and preliminary clinical performance of Myconostica MycAssay Aspergillus when testing serum specimens for diagnosis of invasive Aspergillosis. J Clin Microbiol 2011;49:2169-74
   PubMedGoogle Scholar
• Danylo A, Courtemanche C, Pelletier R, Boudreault AA. Performance of MycAssay Aspergillus DNA real-time PCR assay compared with the galactomannan detection assay for the diagnosis of invasive aspergillosis from serum samples. Med Mycol 2014;52:577-83
   PubMedGoogle Scholar
• Avni T, Leibovici L, Paul M. PCR diagnosis of invasive candidiasis: systematic review and meta-analysis. J Clin Microbiol 2011;49:665-70
   PubMed Web of Science ®Google Scholar
• Nguyen MH, Wissel MC, Shields RK, et al. Performance of Candida real-time polymerase chain reaction, beta-D-glucan assay, and blood cultures in the diagnosis of invasive candidiasis. Clin Infect Dis 2012;54:1240-8
   PubMed Web of Science ®Google Scholar
• Teixeira H, Silva L, Matias C, et al. Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients. Support Care Cancer 2014;22:2861-6
   PubMedGoogle Scholar
• Fortun J, Meije Y, Buitrago MJ, et al. Clinical validation of a multiplex real-time PCR assay for detection of invasive candidiasis in intensive care unit patients. J Antimicrob Chemother 2014
   PubMedGoogle Scholar
• Millon L, Larosa F, Lepiller Q, et al. Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients. Clin Infect Dis 2013;56:e95-101
   PubMed Web of Science ®Google Scholar
• Fan LC, Lu HW, Cheng KB, et al. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One 2013;8:e73099
   PubMed Web of Science ®Google Scholar
• Sun W, Wang K, Gao W, et al. Evaluation of PCR on bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis: a bivariate metaanalysis and systematic review. PLoS One 2011;6:e28467
   PubMed Web of Science ®Google Scholar
• Tuon FF. A systematic literature review on the diagnosis of invasive aspergillosis using polymerase chain reaction (PCR) from bronchoalveolar lavage clinical samples. Rev Iberoam Micol 2007;24:89-94
   PubMedGoogle Scholar
• Reinwald M, Hummel M, Kovalevskaya E, et al. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother 2012;67:2260-7
   PubMed Web of Science ®Google Scholar
• Torelli R, Sanguinetti M, Moody A, et al. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay. J Clin Microbiol 2011;49:4273-8
   PubMed Web of Science ®Google Scholar
• Guinea J, Padilla C, Escribano P, et al. Evaluation of MycAssay Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer. PLoS One 2013;8:e61545
   PubMed Web of Science ®Google Scholar
• McTaggart LR, Wengenack NL, Richardson SE. Validation of the MycAssay Pneumocystis kit for detection of Pneumocystis jirovecii in bronchoalveolar lavage specimens by comparison to a laboratory standard of direct immunofluorescence microscopy, real-time PCR, or conventional PCR. J Clin Microbiol 2012;50:1856-9
   PubMed Web of Science ®Google Scholar
• Lass-Florl C, Follett SA, Moody A, Denning DW. Detection of Aspergillus in lung and other tissue samples using the MycAssay Aspergillus real-time PCR kit. Can J Microbiol 2011;57:765-8
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schulz S, Johrens K, et al. Diagnosis of chronic disseminated candidosis from liver biopsies by a novel PCR in patients with haematological malignancies. Clin Microbiol Infect 2012;18:1010-16
   PubMed Web of Science ®Google Scholar
• Reinwald M, Buchheidt D, Hummel M, et al. Diagnostic performance of an Aspergillus-specific nested PCR assay in cerebrospinal fluid samples of immunocompromised patients for detection of central nervous system aspergillosis. PLoS One 2013;8:e56706
   PubMed Web of Science ®Google Scholar
• Reinwald M, Spiess B, Heinz WJ, et al. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive Aspergillosis enhances diagnostic capabilities. J Clin Microbiol 2013;51:4178-85
   PubMed Web of Science ®Google Scholar
• Morton CO, Clemons KV, Springer J, et al. Real-time PCR and quantitative culture for monitoring of experimental Aspergillus fumigatus intracranial infection in neutropenic mice. J Med Microbiol 2011;60:913-19
   PubMed Web of Science ®Google Scholar
• Hummel M, Spiess B, Kentouche K, et al. Detection of Aspergillus DNA in cerebrospinal fluid from patients with cerebral aspergillosis by a nested PCR assay. J Clin Microbiol 2006;44:3989-93
   PubMed Web of Science ®Google Scholar
• Gade L, Scheel CM, Pham CD, et al. Detection of fungal DNA in human body fluids and tissues during a multistate outbreak of fungal meningitis and other infections. Eukaryot Cell 2013;12:677-83
   PubMedGoogle Scholar
• Dudiuk C, Gamarra S, Leonardeli F, et al. Set of classical PCRs for detection of mutations in Candida glabrata FKS genes linked with Echinocandin resistance. J Clin Microbiol 2014;52:2609-14
   PubMedGoogle Scholar
• Spiess B, Postina P, Reinwald M, et al. Incidence of Cyp51 a key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995–2013. PloS One 2014;9:e103113
   PubMed Web of Science ®Google Scholar
• Spiess B, Seifarth W, Merker N, et al. Development of novel PCR assays to detect azole resistance-mediating mutations of the Aspergillus fumigatus cyp51A gene in primary clinical samples from neutropenic patients. Antimicrob Agents Chemother 2012;56:3905-10
   PubMed Web of Science ®Google Scholar
• Sendid B, Tabouret M, Poirot JL, et al. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999;37:1510-17
   PubMed Web of Science ®Google Scholar
• Mikulska M, Calandra T, Sanguinetti M, et al. The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. Crit Care 2010;14:R222
   PubMed Web of Science ®Google Scholar
• Held J, Kohlberger I, Rappold E, et al. Comparison of (1->3)-beta-D-glucan, mannan/anti-mannan antibodies, and Cand-Tec Candida antigen as serum biomarkers for candidemia. J Clin Microbiol 2013;51:1158-64
   PubMed Web of Science ®Google Scholar
• Prella M, Bille J, Pugnale M, et al. Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies. Diagn Microbiol Infect Dis 2005;51:95-101
   PubMed Web of Science ®Google Scholar
• Lunel FM, Donnelly JP, van der Lee HA, et al. Performance of the new Platelia Candida Plus assays for the diagnosis of invasive Candida infection in patients undergoing myeloablative therapy. Med Mycol 2011;49:848-55
   PubMed Web of Science ®Google Scholar
• Mokaddas E, Khan ZU, Ahmad S, et al. Value of (1-3)-beta-d-glucan, Candida mannan and Candida DNA detection in the diagnosis of candidaemia. Clin Microbiol Infect 2011;17:1549-53
   PubMedGoogle Scholar
• Cuenca-Estrella M, Verweij PE, Arendrup MC, et al. ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. Clin Microbiol Infect 2012;18(Suppl 7):9-18
   PubMed Web of Science ®Google Scholar
• Garcia-Ruiz JC, del Carmen Arilla M, Regulez P, et al. Detection of antibodies to Candida albicans germ tubes for diagnosis and therapeutic monitoring of invasive candidiasis in patients with hematologic malignancies. J Clin Microbiol 1997;35:3284-7
   PubMed Web of Science ®Google Scholar
• Peman J, Zaragoza R, Quindos G, et al. Clinical factors associated with a Candida albicans germ tube antibody positive test in intensive care unit patients. BMC Infect Dis 2011;11:60
   PubMed Web of Science ®Google Scholar
• Leon C, Ruiz-Santana S, Saavedra P, et al. Value of beta-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 2012;38:1315-25
   PubMed Web of Science ®Google Scholar
• Martinez-Jimenez MC, Munoz P, Guinea J, et al. Potential role of Candida albicans germ tube antibody in the diagnosis of deep-seated candidemia. Med Mycol 2014;52:270-5
   PubMed Web of Science ®Google Scholar
• Zaragoza R, Peman J, Quindos G, et al. Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients. Clin Microbiol Infect 2009;15:592-5
   PubMed Web of Science ®Google Scholar